Advisory Board

The PREMIER advisory board will lend us scientific support and external expertise for our purpose. They will give us advice and help us in all scientific issues during the project.

Six members who are experts in the fields of open science / open data and scientific research, as well as a scientific publisher, scientific sponsor and a member of the Volkswagenstiftung are part of the advisory board.

 

List of members of the PREMIER advisory board:

Foto: Mirko Krenzel für VolkswagenStiftung

Dr. Oliver Grewe Scientific Consultant Life Sciences

Member of the promotion team „persons and structures“ of the Volkswagen Foundation. Responsible for the areas natural- and life sciences of the Freigeist Fellowship Program. Prior to that, he was in charge of the areas evolutionary biology, biomedicine and tropical medicine.

Career: Study of biology, musical science, communication studies and philosophy in Münster and Bologna. Doctorate in natural sciences and postdoctoral studies at the Institute for Music Physiology and Music Medicine, Hanover, Germany. Since 2008 employed as scientific advisor at German Academic Scholarship Foundation and the Scientific Commission Lower Saxony, Germany. Outside of this, Mr. Grewe also has been working as business coach for academics since 2015.

Phone:
+49 511 8381-252
E-mail:
grewe@volkswagenstiftung.de

Prof. Dr. Anton Bespalov CEO, Partnership for Assessment and Accreditation of Scientific Practice GmbH

Prof. Bespalov obtained his MD degree from Pavlov Medical University (St. Petersburg) and after completion of PhD studies in St. Petersburg and Utrecht held NIH-supported Fellowships at Medical College of Virginia (Richmond, VA) and Scripps Institute (La Jolla, CA). After habilitation (DMedSci) in 2000, Anton acted as a research director of Valdman Institute of Pharmacology. In 2004, Anton joined Abbott (later AbbVie) but maintained close connections to Pavlov Medical University where he is a professor at the Institute of Pharmacology and chaired the University’s Scientific Advisory Board. During his tenure at Abbott / AbbVie as head of pharmacology department, Anton and his teams have brought several compounds into preclinical and clinical development, supported licensing and due diligence decisions. Anton has established and managed research contracts and collaborations with 100+ biotech companies, CROs and academic labs around the world. Founded and leads several international initiatives on preclinical data quality.

E-mail:
anton.bespalov@paasp.net

Prof. Dr. Michael Gotthardt Professor for Experimental and Translational Cardiology

Dr. Gotthardt is Professor of Experimental & Translational Cardiology at Max-Delbruck-Center for Molecular Medicine and Charité Medical School, Berlin. He has a track record of national and international collaboration including research initiatives (DZHK – German center for cardiovascular research with 28 German institutions), program project grants (SFB-TR/19 “inflammatory cardiomyopathy”, DFG research group “Regulation and deregulation of muscle growth”, DFG Research group “Structure, function, and regulation of the myofibrillar Z-disc interactome”, BMBF E:Bio program CaRNAtion / coordinator Michael Gotthardt), twinning grants between basic scientists and clinicians (institutional and DFG funded), and graduate programs (TransCard Helmholtz Research School / coordinator Michael Gotthardt and the DFG funded MyoGrad program). He is currently collaborating with >50 researchers and provides research reagents and animal models to the community.

E-mail:
gotthardt@mdc-berlin.de

Dr. Katja Hartig Program Director Life Sciences

  • Study of biology 1994 – 2000, University of Bayreuth
  • PhD in molecular biology/genetics 2001-2004, University of Bayreuth
  • DfG project leader and research scientist 2005-2007, University of Bayreuth
  • Since 2007 employed as specialist at the DfG head office, Bonn
  • Since 2010 cross-divisional responsibility for the fields “handling of research data”, infrastructures and Digital Change
  • Responsible for the subject “Epidemiology, Medical Biometry, Medical Informatics” as well as the technology- and methods platform for connected medical research (TMF)
  • Member of the dialogue forum of the medicine informatics initiative of the BMBF
  • Since 2016: deputy group leader “Medicine”
  • Since 2017: member of the DfG project group “ Digital Change in Science”
Phone:
+49 228 885-2359
E-mail:
Katja.Hartig@dfg.de

Dr. Bernd Pulverer Chief Editor and Head of Scientific Publications

Following undergraduate studies in Cambridge, Bernd received his PhD in 1992 from the Ludwig Institute for Cancer Research, London, for uncovering posttranslational regulation of the transcription factors c-Jun and c-Myc by the JNK and MAP kinases. He carried out postdoctoral research at the Ontario Cancer Institute, Toronto, the Fred Hutchinson Cancer Research Center, Seattle and at the University of Innsbruck. Bernd was associate and then senior editor at Nature from 1999 until 2002 and subsequently chief editor of Nature Cell Biology. He has been the chief editor of The EMBO Journal and Head of Scientific Publications at EMBO since 2009.

E-mail:
bernd.pulverer@embo.org

Dr. Paul Schultze-Motel Coordinator - Helmholtz Open Science

Dr. Paul Schultze-Motel has been working for the Open Science Coordination Office of the Helmholtz Association at Helmholtz Centre Potsdam (GFZ German Research Centre for Geosciences) since 2010. His previous positions include stages in science administration at Max-Delbrück-Centrum für Molekulare Medizin and at Technische Universität Berlin as well as jobs in digital publishing with several educational publishers. He is a biologist and received his Ph.D. from Freie Universität Berlin.

Phone:
+49 331 288-1653
E-mail:
paul.schultze-motel@os.helmholtz.de